Načítá se...
First-line treatment of advanced ALK-positive non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer deaths, both within the US and worldwide. There have been major treatment advances in NSCLC over the past decade with the discovery of molecular drivers of NSCLC, which has ushered in an era of personalized medicine. There are...
Uloženo v:
| Vydáno v: | Lung Cancer (Auckl) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217519/ https://ncbi.nlm.nih.gov/pubmed/28210152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S63491 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|